White-label solutions often lack transparency in ingredient sourcing, third-party testing, and quality assurance, which are factors that are critical for building consumer trust
Short-term use may be beneficial for specific concerns, while long-term use should be monitored with professional guidance
Always consult with a licensed healthcare provider before beginning or modifying any wellness or infusion therapy
Limitations: Animal models may not fully translate to humans No standardized human dosing Long-term safety unknown BPC-157 Peptide Therapy Applications in Injury Recovery and Sports Medicine Tendon and Ligament Injuries BPC-157 shows promise in Achilles tendon injuries, rotator cuff tears, ACL/MCL sprains, tennis elbow, and patellar tendonitis
GLP-1 medications are typically recommended for individuals who: Have a BMI of 30 or higher Have a BMI of 27 or higher with obesity-related conditions such as diabetes, high blood pressure, or sleep apnea Have struggled to achieve weight loss through diet and exercise alone A consultation with a healthcare provider is essential to determine if GLP-1 medications are right for you
The FDA has issued multiple 2024 and 2025 warning letters about counterfeit semaglutide and tirzepatide that contained either no active ingredient or completely different substances
